Latest News and Press Releases

HAMILTON, Bermuda, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, today...

HAMILTON, BERMUDA , Sept. 08, 2022 (GLOBE NEWSWIRE) --Company’s Chief Scientific Officer Samuel Wickline, MD, to present on the Company’s innovative and patented OligoPhoreTM platform for the...

Company progressing with plans to focus on its RNA businessAdvancing discussions for divestiture or spin-off of legacy assets, including BentrioTM and AM-125 nasal spraysBentrio revenues were $1.3...

HAMILTON, BERMUDA , Aug. 03, 2022 (GLOBE NEWSWIRE) -- Altamira’s patented RNA delivery technology platform is addressing strong need for reaching target cells outside the liver and for enhanced...

HAMILTON, BERMUDA , Aug. 01, 2022 (GLOBE NEWSWIRE) -- Enrollment to be continued to 160 subjects, adding 24 to ensure adequate statistical powerTop-line data read-out from trial expected in early...

Independent peer-reviewed study confirms high potential for OligoPhore™ delivery platform in RNA-based treatments for osteoarthritisKnock down of JMJD3 gene remarkably mitigated severity of joint...

Company’s novel drug development program AM-411 builds on positive animal dataTreatments for rheumatoid arthritis represent the second largest therapeutic area globally AM-411 to run concurrently...

Peer-reviewed study highlights high potential for cell-penetrating peptides in mRNA-based cancer treatmentsDemonstrates effective uptake and transfection capacity of Altamira’s proprietary delivery...